rediff.com
e.g. Tata motors, Reliance MF, 500570
Fresenius Kabi Oncology Ltd. - Research Center
532545 FKONCO Group (B) BSE data
Add to watchlist
 
Back to Company Page
Results
Statement
More
Profit loss account
(Rs crore)
Mar ' 13 Mar ' 12 Mar ' 11 Mar ' 10 Mar ' 09
Income
Operating income 596.30 524.32 412.37 421.48 262.93
Expenses
Material consumed 187.30 237.48 148.34 126.44 77.96
Manufacturing expenses 22.21 31.29 25.30 33.41 32.48
Personnel expenses 70.32 60.98 56.11 47.59 71.70
Selling expenses - - 18.69 18.30 17.67
Adminstrative expenses 173.47 128.63 63.55 83.19 131.34
Expenses capitalised - - - - -
Cost of sales 453.30 458.38 311.98 308.93 331.16
Operating profit 143.00 65.94 100.39 112.55 -68.23
Other recurring income 1.80 2.90 5.66 6.13 12.30
Adjusted PBDIT 144.80 68.84 106.05 118.67 -55.93
Financial expenses -2.60 17.66 18.03 19.40 21.97
Depreciation 25.79 23.97 16.92 12.51 11.81
Other write offs - - - 0.46 0.46
Adjusted PBT 121.62 27.21 71.10 86.31 -90.17
Tax charges 34.22 20.75 20.76 5.87 2.78
Adjusted PAT 87.40 6.47 50.35 80.44 -92.95
Non recurring items -6.81 44.48 -1.10 -0.21 15.26
Other non cash adjustments - - - - -
Reported net profit 80.59 50.95 49.24 80.23 -77.70
Earnigs before appropriation 144.69 314.10 263.15 213.91 133.68
Equity dividend - - - - -
Preference dividend - - - - -
Dividend tax - - - - -
Retained earnings 144.69 314.10 263.15 213.91 133.68
Close
Add Fresenius Kabi Oncology Ltd. to your Portfolio
 
 
 
*Portfolio will be calculated based on BSE values
Close
Add Fresenius Kabi Oncology Ltd. to your Watchlist
Alert me if price...
*Watchlist will be based on BSE values
Close